Smart Grids Infrastructure Market, 2018-2030

Steffan98702 Jul, 2021Health

Around 300 product candidates are currently under various stages of development for a diverse range of indications. Eight gene therapies are commercially available; of these, Imlygic? (Amgen), Strimvelis? (GSK), Invossa? (TissueGene / Kolon Life Science / Mitsubishi Tanabe Pharma) and Luxturna? (Spark Therapeutics) were approved after 2015

Recent Profiles

nohu90

Nohu90

View Profile

Powell Laboratories

Powell Laboratories

View Profile

Juarez Dugan

Juarez Dugan

View Profile

Klausen Dowling

Klausen Dowling

View Profile

Quinn Sandberg

Quinn Sandberg

View Profile

Garrett Landry

Garrett Landry

View Profile

Flower Delivery Hatch End

Flower Delivery Hatch End

View Profile

Seminar Book Studio Hazratganj

Seminar Book Studio Hazratganj

View Profile

Gustavsen Parks

Gustavsen Parks

View Profile